Youngevity® Essential Life Sciences, a wholly-owned subsidiary of AL International, Inc. (OTC Pink: JCOF), announces that the research of Youngevity® founder, Dr. Joel D. Wallach, BS, DVM, ND, on Selenium continues to be at the forefront of health and prevention with the recent U.S. Food and Drug Administration (FDA) proposed rule requiring the addition of selenium to the list of required nutrients for infant formula products.
Dr. Joel Wallach has been at the front line of Selenium research for nearly 40 years. Selenium is an essential trace mineral that serves many functions in human physiology, including the synthesis of antioxidants (natural substances that neutralize free radical damage), and thyroid and immune function. In 2003, along with Youngevity®, Dr. Wallach successfully petitioned the FDA to establish a Qualified Health Claim for selenium adding that it "may reduce the risk of certain cancers" to labels of dietary supplements containing Selenium.
Dr. Wallach was also the recipient of the Klaus Schwarz Medal in 2011 for his observation done as a researcher at the Yerkes Primate Research Center in Atlanta, Georgia in 1978. Dr. Wallach discovered pancreatic lesions in selenium deficient monkeys identical to those found in human patients discovering the link between selenium deficiencies and some forms of cystic fibrosis; making some forms of cystic fibrosis preventable in humans. This prestigious medal is awarded by the International Association of Bioinorganic Scientists, Inc., honoring trace element researchers for their accomplishments.
Through Dr. Wallach's research, Youngevity® has been able to provide its distributors with high-quality nutrition products based on his concept that there exist a core group of 90 essential nutrients (which includes selenium) that are necessary for optimal health. Specifically, Youngevity® offers a Healthy Heart & Brain Pak™ that not only contains the 90 essential nutrients, but also Youngevity's Award Winning Ultimate™ Selenium to help combat free radical damage.
Youngevity CEO, Steve Wallach, said, "My father, Dr. Wallach, has been lecturing on the health benefits of selenium for over 30 years and continues to lecture almost daily, traveling 300 days a year in order to get the message out to the world. It is his belief, and Youngevity's, that the public is better off by getting the most information available to them in order to come to an educated decision regarding their own health."
Patient-derived organoids: Transforming cancer research and personalized medicine